M. Lukovsky

Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization.

N. Chai, S. Jordan, J. Mirocha, 2010, Transplant immunology.

Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab.

N. Chai, S. Jordan, J. Mirocha, 2011, Transplant immunology.

Analysis of Subcutaneous (SQ) Alemtuzumab Induction Therapy in Highly Sensitized Patients Desensitized With IVIG and Rituximab

J. Wang, N. Reinsmoen, A. Vo, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of Induction Therapy Protocols on Transplant Outcomes in Crossmatch Positive Renal Allograft Recipients Desensitized with IVIG

A. Vo, M. Toyoda, S. Bunnapradist, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.

S. Jordan, A. Vo, M. Toyoda, 2006, Clinical journal of the American Society of Nephrology : CJASN.

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

S. Jordan, N. Reinsmoen, A. Vo, 2008, The New England journal of medicine.